The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
Objectives: The aim of this study was to examine the effectof smoking on the efficacy of raloxifene treatment inpostmenopausal osteoporosis.Materials and methods: In this cross-sectional study,raloxifene HCl (60 mg/day) and 600 mg ionized calcium+ 400 IU vitamin D/day treatment were given to 63 case...
Main Authors: | Savaş Erdem, Ayşe Filiz Yavuz Avşar, Hüseyin Levent Keskin, Gülin Feykan Yeğin Akçay, Elçin İşlek Seçen |
---|---|
Format: | Article |
Language: | English |
Published: |
Modestum Publishing LTD
2012-12-01
|
Series: | Journal of Clinical and Experimental Investigations |
Subjects: | |
Online Access: | http://www.jceionline.org/upload/sayi/11/JCEI-00507.pdf |
Similar Items
-
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01) -
Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
by: Abdurrahman Yeter, et al.
Published: (2014-12-01) -
Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)